Marilyn L. Moy MD
Adjunct Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine
72 E. Concord Street marilyn.moy@va.gov
Sections
Pulmonary, Allergy, Sleep & Critical Care Medicine
Biography
Marilyn L. Moy, M.D., M.Sc., Associate Professor of Medicine, Harvard Medical School, is a Staff Pulmonary Physician at VA Boston Healthcare System. She is Medical Director of the Pulmonary Rehabilitation Program, accredited by the American Association of Cardiovascular and Pulmonary Rehabilitation. Dr. Moy studies the role of physical activity (PA) in the risk stratification of COPD, technology-based interventions to promote PA, and the biological mechanisms underlying the beneficial effects of PA on COPD outcomes. Her work has contributed to the field of telehealth medicine.
Dr. Moy is internationally recognized as an expert in Pulmonary Rehabilitation. She was the 2016-2017 Chair of the Program Committee of the Rehabilitation Assembly of the American Thoracic Society. She has been an invited speaker at the European Respiratory Congress in Munich, Germany and Amsterdam, Holland. She serves on the Research Advocacy Committee of the ATS.
As the Principal Investigator on VA and NIH funded grants, Dr. Moy published one of the first papers demonstrating that low PA is associated with increased risk for acute exacerbations in COPD. Dr. Moy has developed a novel internet-mediated, pedometer based intervention to promote PA in COPD. Her work was recognized with the 2017 Massachusetts Pulmonary Section award for best clinical research abstract. Dr. Moy also examines biological mechanisms including the relationship between PA and telomere length, and the epigenetic changes associated with improvements in PA. Dr. Moy is VA Boston's 2017 nominee for the Presidential Early Career Award for Scientists and Engineers.
Dr. Moy is a Co-Investigator for a pragmatic trial examining a PA coaching intervention (PCORI), and a trial on the efficacy of Tai Chi to maintain benefits after conventional pulmonary rehabilitation in COPD (NIH-NCCIH). Dr. Moy has been the site-PI for NHLBI clinical trials.
Education
Medicine, MD, Harvard Medical School
Epidemiology, MSc, Harvard School of Public Health
Biology, AB, Radcliffe College
Publications
Moy M, Garvey C, Lareau S. Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2024 Nov 01; 210(9):P3-P5. PMID: 39485124.
Published on 7/25/2024Berube MN, Robinson SA, Wan ES, Mongiardo MA, Finer EB, Moy ML. Physical Activity and Systemic Biomarkers in Persons With COPD: Insights from a Web-Based Pedometer-Mediated Intervention. Chronic Obstr Pulm Dis. 2024 Jul 25; 11(4):369-381. PMID: 38809105.
Published on 7/11/2024Wang Z, Koutrakis P, Liu M, Vieira CLZ, Coull BA, Maher EF, Moy ML, Huang S, Garshick E. Residential radon decay products are associated with cough and phlegm in patients with COPD. Ecotoxicol Environ Saf. 2024 Sep 01; 282:116693. PMID: 38991307.
Published on 7/11/2024Bamonti PM, Rose GA, Park S, Silberbogen AK, Moye J, Moy ML. Emotional Distress and Physical Activity Engagement in U.S. Veterans With Chronic Obstructive Pulmonary Disease: A Qualitative Study. Ann Behav Med. 2024 Jul 11; 58(8):539-551. PMID: 38847496.
Published on 5/28/2024Moy ML. Maintenance Pulmonary Rehabilitation: An Update and Future Directions. Respir Care. 2024 May 28; 69(6):724-739. PMID: 38744473.
Published on 3/22/2024Zhang CL, Maccarone JR, Grady ST, Collins CM, Moy ML, Hart JE, Kang CM, Coull BA, Schwartz JD, Koutrakis P, Garshick E. Indoor and ambient black carbon and fine particulate matter associations with blood biomarkers in COPD patients. Sci Total Environ. 2024 Jun 01; 927:171897. PMID: 38522542.
Published on 12/2/2023Kraemer KM, Kilgore K, Litrownik D, Jean-Laurent B, Wayne PM, Richardson CR, Moy ML, Yeh GY. A Web-Based Mind-Body Intervention (Mindful Steps) for Promoting Walking in Chronic Cardiopulmonary Disease: Insights From a Qualitative Study. Glob Adv Integr Med Health. 2023; 12:27536130231212169. PMID: 38050584.
Published on 10/5/2023McHugh EG, Grady ST, Collins CM, Moy ML, Hart JE, Coull BA, Schwartz JD, Koutrakis P, Zhang J, Garshick E. Pulmonary, inflammatory, and oxidative effects of indoor nitrogen dioxide in patients with COPD. Environ Epidemiol. 2023 Oct; 7(5):e271. PMID: 37840862.
Published on 9/29/2023Robinson SA, Shimada SL, Sliwinski SK, Wiener RS, Moy ML. Stakeholder Perceptions of a Web-Based Physical Activity Intervention for COPD: A Mixed-Methods Study. J Clin Med. 2023 Sep 29; 12(19). PMID: 37834938.
Published on 9/13/2023Bamonti PM, Perndorfer C, Robinson SA, Mongiardo MA, Wan ES, Moy ML. Depression Symptoms and Physical Activity in Veterans With COPD: Insights From a Web-Based, Pedometer-Mediated Physical Activity Intervention. Ann Behav Med. 2023 Sep 13; 57(10):855-865. PMID: 37260290.